{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:38:31Z","timestamp":1791409111735,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002736","name":"Citizens United for Research in Epilepsy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002782","name":"CURE Childhood Cancer Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS118107"],"award-info":[{"award-number":["K08NS118107"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejphar.2025.177327","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T11:14:47Z","timestamp":1738667687000},"page":"177327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Machine learning enables high-throughput, low-replicate screening for novel anti-seizure targets and compounds using combined movement and calcium fluorescence in larval zebrafish"],"prefix":"10.1016","volume":"991","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-4550","authenticated-orcid":false,"given":"Christopher Michael","family":"McGraw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapurna","family":"Poduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177327_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054166","article-title":"Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs","volume":"8","author":"Afrikanova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177327_bib2","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/ncomms3410","article-title":"Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment","volume":"4","author":"Baraban","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177327_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuroscience.2004.11.031","article-title":"Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression","volume":"131","author":"Baraban","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177327_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76056-8","article-title":"Organophosphorus diisopropylfluorophosphate (DFP) intoxication in zebrafish larvae causes behavioral defects, neuronal hyperexcitation and neuronal death","volume":"10","author":"Brenet","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177327_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2017.03.002","article-title":"Spectral properties of the zebrafish visual motor response","volume":"646","author":"Burton","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177327_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vascn.2017.07.002","article-title":"Measuring drug absorption improves interpretation of behavioral responses in a larval zebrafish locomotor assay for predicting seizure liability","volume":"88","author":"Cassar","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2025.177327_bib7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1528-1167.2012.03495.x","article-title":"Successful use of fenfluramine as an add-on treatment for Dravet syndrome","volume":"53","author":"Ceulemans","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.177327_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12354","article-title":"Ultrasensitive fluorescent proteins for imaging neuronal activity","volume":"499","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177327_bib9","series-title":"An Introduction to Bootstrap Methods with Applications to R","author":"Chernick","year":"2014"},{"key":"10.1016\/j.ejphar.2025.177327_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jat.4244","article-title":"Caffeine-induced neurotoxicity mediated by Nrf2 pathway in PC12 cells and zebrafish larvae","volume":"42","author":"Chian","year":"2022","journal-title":"J. Appl. Toxicol. JAT"},{"key":"10.1016\/j.ejphar.2025.177327_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jneumeth.2015.08.034","article-title":"Acute and chronic pharmacological models of generalized absence seizures","volume":"260","author":"Cortez","year":"2016","journal-title":"J. Neurosci. Methods, Methods and Models in Epilepsy Research"},{"key":"10.1016\/j.ejphar.2025.177327_bib12","first-page":"1","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejphar.2025.177327_bib13","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0068-15.2015","article-title":"Large-Scale phenotype-based antiepileptic drug screening in a zebrafish model of Dravet syndrome","volume":"2","author":"Dinday","year":"2015","journal-title":"eNeuro"},{"key":"10.1016\/j.ejphar.2025.177327_bib14","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1038\/s41598-023-30303-w","article-title":"Zebrafish Larvae Position Tracker (Z-LaP Tracker): a high-throughput deep-learning behavioral approach for the identification of calcineurin pathway-modulating drugs using zebrafish larvae","volume":"13","author":"Gore","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177327_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02221-y","article-title":"Phenotypic analysis of catastrophic childhood epilepsy genes","volume":"4","author":"Griffin","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejphar.2025.177327_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151148","article-title":"Epilepsy, behavioral abnormalities, and physiological comorbidities in syntaxin-binding protein 1 (STXBP1) mutant zebrafish","volume":"11","author":"Grone","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177327_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.753936","article-title":"Pericardial injection of kainic acid induces a chronic epileptic state in larval zebrafish","volume":"14","author":"Heylen","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177327_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00401706.1970.10488634","article-title":"Ridge regression: biased estimation for nonorthogonal problems","volume":"12","author":"Hoerl","year":"1970","journal-title":"Technometrics"},{"key":"10.1016\/j.ejphar.2025.177327_bib19","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.045815","article-title":"Machine learning discriminates a movement disorder in a zebrafish model of Parkinson's disease","volume":"13","author":"Hughes","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ejphar.2025.177327_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jbio.201200144","article-title":"Comparing phototoxicity during the development of a zebrafish craniofacial bone using confocal and light sheet fluorescence microscopy techniques","volume":"6","author":"Jemielita","year":"2013","journal-title":"J. Biophot."},{"key":"10.1016\/j.ejphar.2025.177327_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2025.177327_bib22","author":"LaCoursiere"},{"key":"10.1016\/j.ejphar.2025.177327_bib23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.177327_bib24","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s11064-017-2222-z","article-title":"Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs","volume":"42","author":"L\u00f6scher","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2025.177327_bib25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2025.177327_bib26","series-title":"Assay Guidance Manual","year":"2004"},{"key":"10.1016\/j.ejphar.2025.177327_bib27","author":"McInnes"},{"key":"10.1016\/j.ejphar.2025.177327_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.836573","article-title":"Neural activity correlates with behavior effects of anti-seizure drugs efficacy using the zebrafish pentylenetetrazol seizure model","volume":"13","author":"Milder","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177327_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejphar.2025.177327_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.2518","article-title":"Monitoring neural activity with bioluminescence during natural behavior","volume":"13","author":"Naumann","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177327_bib31","author":"Park"},{"key":"10.1016\/j.ejphar.2025.177327_bib32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1126\/science.abi8870","article-title":"MIC-Drop: a platform for large-scale in vivo CRISPR screens","volume":"373","author":"Parvez","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.177327_bib33","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0337-21.2022","article-title":"Differential electrographic signatures generated by mechanistically-diverse seizurogenic compounds in the larval zebrafish brain","volume":"9","author":"Pinion","year":"2022","journal-title":"eneuro"},{"key":"10.1016\/j.ejphar.2025.177327_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105738","article-title":"Mosaic and non-mosaic protocadherin 19 mutation leads to neuronal hyperexcitability in zebrafish","volume":"169","author":"Robens","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2025.177327_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"10.1016\/j.ejphar.2025.177327_bib36","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/s41598-017-03087-z","article-title":"Optical mapping of neuronal activity during seizures in zebrafish","volume":"7","author":"Turrini","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177327_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/biomedicines10050951","article-title":"Multimodal characterization of seizures in zebrafish larvae","volume":"10","author":"Turrini","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2025.177327_bib38","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1038\/s41598-017-06646-6","article-title":"4-dimensional functional profiling in the convulsant-treated larval zebrafish brain","volume":"7","author":"Winter","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177327_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/1087057111405851","article-title":"Illustration of SSMD, z score, SSMD\u2217, z\u2217 score, and t statistic for hit selection in RNAi high-throughput screens","volume":"16","author":"Zhang","year":"2011","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejphar.2025.177327_bib40","article-title":"Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177327_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:35:24Z","timestamp":1740461724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925000809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":41,"alternative-id":["S0014299925000809"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177327","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.01.606228","asserted-by":"object"}]},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning enables high-throughput, low-replicate screening for novel anti-seizure targets and compounds using combined movement and calcium fluorescence in larval zebrafish","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177327"}}